Answers are grounded in this paper and cite their sources.
High Resolution Image Download MS PowerPoint Slide A Cu(II)-catalyzed asymmetric cascade process was successfully developed by the dimerization of β,γ-unsaturated α-keto tryptophol esters or β,γ-unsaturated α-keto tryptamino amides under mild reaction conditions, furnishing the corresponding macrocyclic dilactones and dilactams in good yields with excellent regio-, diastereo-, and enantioselectivities. The transformation involved a four-step cascade of double Friedel–Crafts alkylation and double N -hemiketalization, providing efficient access to a variety of macrocyclic dilactone and dilactam scaffolds bearing four new stereocenters in a one-pot and highly atom-economic fashion. The resultant chiral macrocyclic compounds were further applied as ligands in the copper-catalyzed asymmetric Friedel–Crafts alkylation reactions and also tested as multifunctional chiral host molecules in binding with quinine and quinidine.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: